All In Biotech

Drug Trial Radar · NCT00711802

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

An Evaluation of the Safety, Efficacy and Pharmacokinetics of Daptomycin in Pediatric Subjects Aged One to Seventeen Years With Complicated Skin and Skin Structure Infections Caused by Gram-Positive Pathogens

Last checked: Nov 19, 2026Latest source record: Sep 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 396 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

396

Actual

Start

Jul 23, 2008

Primary completion

Oct 11, 2013

Study completion Oct 11, 2013

Sponsor

Sponsor type
Industry
First posted
Jul 9, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 1 year, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, evaluator-blinded, randomized, comparative study designed to assess the safety, efficacy, and pharmacokinetics (PK) of daptomycin in pediatric subjects ages 1 to 17 years, inclusive, with complicated skin and skin structure infections (cSSSI) caused by Gram-positive pathogens.

Conditions

  • Skin Diseases, Infectious

Interventions

  • DaptomycinDrug

  • Standard of Care (SOC)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline through 14 days after last dose of study drug

Locations

30 sites in 3 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Children's Hospital Research Center Oakland

    Oakland, California

  • Children's Hospital of Orange County

    Orange, California

  • Rady Children's Hospital - San Diego

    San Diego, California

  • University of South Florida College of Medicine

    Tampa, Florida

  • Emory University

    Atlanta, Georgia

  • University of Chicago

    Chicago, Illinois

  • Children's Hospital of Michigan

    Detroit, Michigan

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Robert Wood Johnson Medical School

    New Brunswick, New Jersey

  • SUNY Downstate Medical Center

    Brooklyn, New York

  • Montifiore Medical Center

    The Bronx, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Children's Hospital Medical Center of Akron

    Akron, Ohio

  • University Hospitals Case Medical Center

    Cleveland, Ohio

  • Toledo Children's Hospital

    Toledo, Ohio

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

  • LeBonheur Children's Medical Center

    Memphis, Tennessee

  • Vanderbilt University Medical Center and Children's Hospital

    Nashville, Tennessee

  • Cook Children's Medical Center

    Fort Worth, Texas

  • Texas Children's Hospital

    Houston, Texas

  • The University of Texas Health Science Center

    Houston, Texas

  • Medisys Hospital

    Bangalore, India

  • MS Ramaiah

    Bangalore, India

  • MV Hospital and Research Center

    Lucknow, India

  • BYL Nair Hospital

    Mumbai, India

  • Lokmanya Tilak Municipal Medical College

    Mumbai, India

  • KEM Hospital

    Pune, India

  • Ruby Hall Clinic

    Pune, India

  • Hospital Del Nino

    Panama City, Panama

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.